vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Hess Midstream LP (HESM). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $204.1M, roughly 2.4× Hess Midstream LP). Hess Midstream LP runs the higher net margin — 77.3% vs -10.1%, a 87.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (17.0% CAGR vs -25.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Hess Corporation is an American global independent energy company involved in the exploration and production of crude oil and natural gas. It was formed by the merger of Hess Oil and Chemical and Amerada Petroleum in 1968. Leon Hess was CEO from the early 1960s until 1995, after which his son John B Hess succeeded him as chairman and CEO. The company agreed to be acquired by rival oil company Chevron in October 2023, and the acquisition closed in July 2025.

CLOV vs HESM — Head-to-Head

Bigger by revenue
CLOV
CLOV
2.4× larger
CLOV
$487.7M
$204.1M
HESM
Growing faster (revenue YoY)
CLOV
CLOV
+42.6% gap
CLOV
44.7%
2.1%
HESM
Higher net margin
HESM
HESM
87.4% more per $
HESM
77.3%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
17.0%
-25.3%
HESM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
HESM
HESM
Revenue
$487.7M
$204.1M
Net Profit
$-49.3M
$157.7M
Gross Margin
Operating Margin
-10.1%
116.7%
Net Margin
-10.1%
77.3%
Revenue YoY
44.7%
2.1%
Net Profit YoY
-123.2%
-2.3%
EPS (diluted)
$-0.10
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
HESM
HESM
Q1 26
$487.7M
$204.1M
Q4 25
$487.7M
$404.2M
Q3 25
$496.6M
$420.9M
Q2 25
$477.6M
$414.2M
Q1 25
$462.3M
$382.0M
Q4 24
$337.0M
$395.9M
Q3 24
$331.0M
$378.5M
Q2 24
$356.3M
$365.5M
Net Profit
CLOV
CLOV
HESM
HESM
Q1 26
$-49.3M
$157.7M
Q4 25
$-49.3M
$93.3M
Q3 25
$-24.4M
$97.7M
Q2 25
$-10.6M
$90.3M
Q1 25
$-1.3M
$71.6M
Q4 24
$-22.1M
$70.4M
Q3 24
$-9.2M
$58.6M
Q2 24
$7.4M
$49.5M
Gross Margin
CLOV
CLOV
HESM
HESM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
HESM
HESM
Q1 26
-10.1%
116.7%
Q4 25
-10.1%
62.2%
Q3 25
-4.9%
61.5%
Q2 25
-2.2%
62.8%
Q1 25
-0.3%
62.1%
Q4 24
-6.4%
61.4%
Q3 24
-2.7%
61.2%
Q2 24
2.0%
60.8%
Net Margin
CLOV
CLOV
HESM
HESM
Q1 26
-10.1%
77.3%
Q4 25
-10.1%
23.1%
Q3 25
-4.9%
23.2%
Q2 25
-2.2%
21.8%
Q1 25
-0.3%
18.7%
Q4 24
-6.6%
17.8%
Q3 24
-2.8%
15.5%
Q2 24
2.1%
13.5%
EPS (diluted)
CLOV
CLOV
HESM
HESM
Q1 26
$-0.10
$0.68
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
HESM
HESM
Cash + ST InvestmentsLiquidity on hand
$95.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
Total Assets
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
HESM
HESM
Q1 26
$95.3M
Q4 25
$78.3M
$1.9M
Q3 25
$5.5M
Q2 25
$4.5M
Q1 25
$6.1M
Q4 24
$194.5M
$4.3M
Q3 24
$288.0M
$10.3M
Q2 24
$254.8M
$99.6M
Total Debt
CLOV
CLOV
HESM
HESM
Q1 26
Q4 25
$3.8B
Q3 25
Q2 25
Q1 25
Q4 24
$3.5B
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
HESM
HESM
Q1 26
$308.7M
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Total Assets
CLOV
CLOV
HESM
HESM
Q1 26
$541.0M
Q4 25
$541.0M
$4.4B
Q3 25
$559.7M
$4.4B
Q2 25
$575.0M
$4.4B
Q1 25
$583.7M
$4.3B
Q4 24
$580.7M
$4.2B
Q3 24
$653.0M
$4.1B
Q2 24
$674.2M
$4.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
HESM
HESM
Operating Cash FlowLast quarter
$0
$253.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
51.4%
Cash ConversionOCF / Net Profit
1.61×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
HESM
HESM
Q1 26
$0
$253.3M
Q4 25
$-66.9M
$245.6M
Q3 25
$12.1M
$258.9M
Q2 25
$5.4M
$276.9M
Q1 25
$-16.3M
$202.4M
Q4 24
$34.8M
$258.5M
Q3 24
$50.0M
$224.9M
Q2 24
$44.8M
$271.6M
Free Cash Flow
CLOV
CLOV
HESM
HESM
Q1 26
Q4 25
$-69.0M
$178.9M
Q3 25
$11.4M
$178.9M
Q2 25
$4.8M
$213.5M
Q1 25
$-16.5M
$156.9M
Q4 24
$33.3M
$163.4M
Q3 24
$49.6M
$132.6M
Q2 24
$44.4M
$207.7M
FCF Margin
CLOV
CLOV
HESM
HESM
Q1 26
Q4 25
-14.1%
44.3%
Q3 25
2.3%
42.5%
Q2 25
1.0%
51.5%
Q1 25
-3.6%
41.1%
Q4 24
9.9%
41.3%
Q3 24
15.0%
35.0%
Q2 24
12.5%
56.8%
Capex Intensity
CLOV
CLOV
HESM
HESM
Q1 26
51.4%
Q4 25
0.4%
16.5%
Q3 25
0.1%
19.0%
Q2 25
0.1%
15.3%
Q1 25
0.0%
11.9%
Q4 24
0.5%
24.0%
Q3 24
0.1%
24.4%
Q2 24
0.1%
17.5%
Cash Conversion
CLOV
CLOV
HESM
HESM
Q1 26
1.61×
Q4 25
2.63×
Q3 25
2.65×
Q2 25
3.07×
Q1 25
2.83×
Q4 24
3.67×
Q3 24
3.84×
Q2 24
6.04×
5.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

HESM
HESM

Affiliate services$197.9M97%
Third-party services$6.2M3%

Related Comparisons